Literature DB >> 17606684

Molecular epidemiology of imipenem-resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital.

Sandra Quinteira, Filipa Grosso, Helena Ramos, Luísa Peixe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17606684      PMCID： PMC2043188          DOI： 10.1128/AAC.00267-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  11 in total

1.  Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain.

Authors:  F Lopez-Otsoa; L Gallego; K J Towner; L Tysall; N Woodford; D M Livermore
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

2.  Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods.

Authors:  Ronald N Jones; Tamara R Anderegg; Jana M Swenson
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

3.  Worldwide emergence of carbapenem-resistant Acinetobacter spp.

Authors:  M Afzal-Shah; D M Livermore
Journal:  J Antimicrob Chemother       Date:  1998-05       Impact factor: 5.790

Review 4.  Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.

Authors:  L Poirel; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

5.  Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain.

Authors:  Lucia Gallego; Kevin J Towner
Journal:  J Med Microbiol       Date:  2001-01       Impact factor: 2.472

6.  Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England.

Authors:  Juliana M Coelho; Jane F Turton; Mary E Kaufmann; Judith Glover; Neil Woodford; Marina Warner; Marie-France Palepou; Rachel Pike; Tyrone L Pitt; Bharat C Patel; David M Livermore
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

7.  Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods.

Authors:  M A Visalli; M R Jacobs; T D Moore; F A Renzi; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

8.  Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula.

Authors:  G J Da Silva; S Quinteira; E Bértolo; J C Sousa; L Gallego; A Duarte; L Peixe
Journal:  J Antimicrob Chemother       Date:  2004-06-09       Impact factor: 5.790

9.  Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Daniel Aubert; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

10.  Characterization of Acinetobacter haemolyticus aac(6')-Ig gene encoding an aminoglycoside 6'-N-acetyltransferase which modifies amikacin.

Authors:  T Lambert; G Gerbaud; M Galimand; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191
View more
  16 in total

1.  Use of the accessory genome for characterization and typing of Acinetobacter baumannii.

Authors:  Jane F Turton; Buket Baddal; Claire Perry
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

2.  Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.

Authors:  Alejandro Beceiro; Enrique Llobet; Jesús Aranda; José Antonio Bengoechea; Michel Doumith; Michael Hornsey; Hiran Dhanji; Henrik Chart; Germán Bou; David M Livermore; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

3.  Role of common blaOXA-24/OXA-40-carrying platforms and plasmids in the spread of OXA-24/OXA-40 among Acinetobacter species clinical isolates.

Authors:  Filipa Grosso; Sandra Quinteira; Laurent Poirel; Ângela Novais; Luísa Peixe
Journal:  Antimicrob Agents Chemother       Date:  2012-04-23       Impact factor: 5.191

Review 4.  Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Authors:  Ming-Feng Lin; Chung-Yu Lan
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

Review 5.  OXA β-lactamases.

Authors:  Benjamin A Evans; Sebastian G B Amyes
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 6.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

7.  Urban riverine environment is a source of multidrug-resistant and ESBL-producing clinically important Acinetobacter spp.

Authors:  Ana Maravić; Mirjana Skočibušić; Željana Fredotović; Ivica Šamanić; Svjetlana Cvjetan; Mia Knezović; Jasna Puizina
Journal:  Environ Sci Pollut Res Int       Date:  2015-10-21       Impact factor: 4.223

8.  The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.

Authors:  Ignasi Roca; Paula Espinal; Xavier Vila-Farrés; Jordi Vila
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

9.  Time dependent enhanced resistance against antibiotics & metal salts by planktonic & biofilm form of Acinetobacter haemolyticus MMC 8 clinical isolate.

Authors:  Sharvari Vijaykumar Gaidhani; Aartee Vishnu Raskar; Sharmishtha Poddar; Shriya Gosavi; Praveen Kishore Sahu; Karishma Rajendra Pardesi; Shobhana V Bhide; Balu Ananada Chopade
Journal:  Indian J Med Res       Date:  2014-11       Impact factor: 2.375

Review 10.  Acquired Class D β-Lactamases.

Authors:  Nuno T Antunes; Jed F Fisher
Journal:  Antibiotics (Basel)       Date:  2014-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.